Gallagher Duncan 4
4 · Health Catalyst, Inc. · Filed Dec 27, 2024
Insider Transaction Report
Form 4
Gallagher Duncan
Director
Transactions
- Sale
Common Stock
2024-12-23$6.98/sh−4,500$31,415→ 74,438 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 26, 2024 in accordance with Rule 10b5-1.